BeyondSpring posts corporate presentation spotlighting plinabulin immune-modulating cancer therapy pipelinePUBT·Jul 9 at 01:18 PMBYSI+6.32%
BeyondSpring files Form 3 for CFO Na Li showing no beneficial ownershipPUBT·Jul 6 at 12:09 PMBYSI+6.32%
BeyondSpring amends filing to disclose CEO Min Qiu pay package, including USD 100,000 salaryPUBT·Jun 29 at 03:31 PMBYSI+6.32%
BeyondSpring appoints Min Qiu as CEO and Na Li as CFO; Lan Huang to remain as ChairTradingView·Jun 4 at 06:33 AMBYSI+6.32%
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026Unusual Whales·Mar 30 at 06:32 AMSBIO-0.24%BYSI+6.32%
BeyondSpring Files 2025 Annual Report on Form 10-KUnusual Whales·Mar 25 at 03:31 PMFBT-0.36%PBE+0.69%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Mar 3 at 11:05 AMCALC+2.37%IXJ+0.12%
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference | BYSI Stock NewsStockTitan·Feb 8 at 10:15 PMPBE+0.69%IBB-0.08%
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path | BYSI Stock NewsStockTitan·Dec 11, 2025 at 10:00 PMBYSI+6.32%
